Innovation and Health Sector Transformation: Panel Discussion
Urgency grows to provide greater value at lower cost throughout the health sector. Current trends, such as quality and price transparency, provide newly fertile ground for innovation regarding products, processes and business models.
In response, a recent event at Boston University School of Management, Innovation and Health Sector Transformation; drew together thought-leaders from across industry and academia to explore the transformative role that innovation will play in the sector over the next 10 years.
The panel was comprised of: N. Stephen Ober, Director, BU MD/MBA Dual Degree Program (as moderator); Regina E. Herzlinger, Nancy R. McPherson Professor of Business Administration Chair, Harvard Business School; Andrew Dreyfus, Executive VP, Health Care Services, Blue Cross Blue Shield Of Mass.; and Dane Bedward, Senior VP, Genzyme International.
This video brings you highlights from the event’s panel discussion.
- Problems in Global Competitiveness Caused by Our Multiple-Payer Healthcare Systems
- Blue Cross Blue Shield’s Innovations in Insurance Payments: Quality vs. Complexity
- Genzyme’s Perpsective: Valuing Innovation that Benefits Innovators & the Health System